Intensity Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $8,319,000.
Profit Margin
| 2019 | 0 | -5.22M | |
|---|---|---|---|
| 2020 | 0 | -5.95M | |
| 2021 | 0 | -7.89M | |
| 2022 | 0 | -7.45M | |
| 2023 | 0 | -10.53M |
INTS Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 147K | 179.03K | 0 | 0 | 0 |
Gross profit | -147K | -179.03K | 0 | 0 | 0 |
Operating exp. | |||||
Research and development | 4.78M | 5.13M | 5.85M | 5.05M | 4.43M |
Selling and marketing | -147K | 0 | 0 | 0 | 0 |
Total operating expenses | 8.31M | 7.55M | 8.01M | 6.22M | 5.67M |
Operating income | -8.31M | -7.63M | -8.01M | -6.22M | -5.67M |
Other income (expenses), net | -2.21M | 49.05K | 118.12K | 192.76K | 295.69K |
Income before tax | -10.53M | -7.58M | -7.89M | -6.03M | -5.37M |
Income tax expense | 0 | -131.90K | -2.60K | -74.00K | -150.70K |
Net income | -10.53M | -7.45M | -7.89M | -5.95M | -5.22M |
Earnings per share | |||||
Basic EPS | -1.38 | -0.57 | -0.6 | -0.45 | -0.4 |
Diluted EPS | -1.38 | -0.57 | -0.6 | -0.45 | -0.4 |
| Data source |